Differential effects of Vav‐promoter‐driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis

Overexpression of BCLX and BFL1/A1 has been reported in various human malignancies and is associated with poor prognosis and drug resistance, identifying these prosurvival BCL2 family members as putative drug targets. We have generated transgenic mice that express human BFL1 or human BCLX protein th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuzlak, Selma, Haschka, Manuel D., Mokina, Anna‐Maria, Rülicke, Thomas, Cory, Suzanne, Labi, Verena, Villunger, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Editor's Choice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947286/
https://www.ncbi.nlm.nih.gov/pubmed/29498802
http://dx.doi.org/10.1111/febs.14426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947286/
https://www.ncbi.nlm.nih.gov/pubmed/29498802
http://dx.doi.org/10.1111/febs.14426

Ejemplares similares